Pharmaceutical enterprises ready to land in State-owned industrial park

Guizhou Runyang Pharmaceutical Co plans to invest a total of 120 million yuan ($16.68 million) to build a project in Phase Four of the Guiyang Health and Pharmaceutical (Chemical Pharmaceutical) Industrial Park in Xifeng county, Guiyang city, capital of Southwest China's Guizhou province.

This project will commence construction in the second half of this year. Once operational, it is expected to produce an annual Captopril output of 200 metric tons, with an expected annual output value of 120 million yuan.

The introduction of this project adds pharmaceutical intermediates (chemical raw materials) for antihypertensive drugs to the park's chemical pharmaceutical industry chain. 

The Guiyang Health and Pharmaceutical (Chemical Pharmaceutical) Industrial Park was implemented by the State-owned Guiyang Heyi Investment Co. The park is positioned as a gathering area for pharmaceutical intermediates, bulk chemical drug manufacturers, and high-end drug formulation enterprises.

"So far, six companies, including Guizhou Zhongsen Pharmaceuticals, have signed agreements to enter the park," said Wu Yun, deputy general manager of Guiyang Heyi Investment Co.

Next, Guiyang Heyi Investment Co will promote project construction to help the high-quality development of the local health and pharmaceutical industry.